Pavmed Inc Stock Market Value
PAVM Stock | USD 1.00 0.01 0.99% |
Symbol | PAVmed |
PAVmed Inc Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PAVmed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PAVmed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PAVmed.
12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in PAVmed on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding PAVmed Inc or generate 0.0% return on investment in PAVmed over 720 days. PAVmed is related to or competes with Neuropace, Hyperfine, Orthopediatrics Corp, Inari Medical, Tela Bio, MaxCyte, and Clearpoint Neuro. PAVmed Inc. operates as a medical device company in the United States More
PAVmed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PAVmed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PAVmed Inc upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 6.4 | |||
Information Ratio | 0.0909 | |||
Maximum Drawdown | 63.57 | |||
Value At Risk | (8.93) | |||
Potential Upside | 9.46 |
PAVmed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PAVmed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PAVmed's standard deviation. In reality, there are many statistical measures that can use PAVmed historical prices to predict the future PAVmed's volatility.Risk Adjusted Performance | 0.0903 | |||
Jensen Alpha | 1.02 | |||
Total Risk Alpha | (0.46) | |||
Sortino Ratio | 0.1241 | |||
Treynor Ratio | (1.00) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PAVmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PAVmed Inc Backtested Returns
PAVmed appears to be abnormally volatile, given 3 months investment horizon. PAVmed Inc maintains Sharpe Ratio (i.e., Efficiency) of 0.0758, which implies the company had a 0.0758% return per unit of standard deviation over the last 3 months. By inspecting PAVmed's technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please evaluate PAVmed's Mean Deviation of 5.5, market risk adjusted performance of (0.99), and Coefficient Of Variation of 944.32 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PAVmed holds a performance score of 5. The firm holds a Beta of -0.91, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning PAVmed are expected to decrease slowly. On the other hand, during market turmoil, PAVmed is expected to outperform it slightly. Please check PAVmed's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether PAVmed's historical price patterns will revert.
Auto-correlation | 0.73 |
Good predictability
PAVmed Inc has good predictability. Overlapping area represents the amount of predictability between PAVmed time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PAVmed Inc price movement. The serial correlation of 0.73 indicates that around 73.0% of current PAVmed price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.73 | |
Spearman Rank Test | 0.65 | |
Residual Average | 0.0 | |
Price Variance | 0.93 |
PAVmed Inc lagged returns against current returns
Autocorrelation, which is PAVmed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PAVmed's stock expected returns. We can calculate the autocorrelation of PAVmed returns to help us make a trade decision. For example, suppose you find that PAVmed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
PAVmed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PAVmed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PAVmed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PAVmed stock over time.
Current vs Lagged Prices |
Timeline |
PAVmed Lagged Returns
When evaluating PAVmed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PAVmed stock have on its future price. PAVmed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PAVmed autocorrelation shows the relationship between PAVmed stock current value and its past values and can show if there is a momentum factor associated with investing in PAVmed Inc.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out PAVmed Correlation, PAVmed Volatility and PAVmed Alpha and Beta module to complement your research on PAVmed. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
PAVmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.